Safety and Efficacy of Lastacaft® for the Prevention of Itching Associated With Allergic Conjunctivitis in Korea

Completed

• Conditions: Conjunctivitis, Allergic
• Interventions: Drug: Alcaftadine Ophthalmic Solution 0.25%

• Registration Number: NCT02555761
• Lead Sponsor: Allergan

Brief Summary

This post-marketing surveillance study will assess the safety and efficacy of Lastacaft® Opthalmic Solution 0.25% (Alcaftadine) for the prevention of itching associated with Allergic Conjunctivitis as prescribed as standard of care in clinical practice in Korea.

Detailed Description

Not available

Study Timeline

• Study First Submitted: 2015-09-18
• Study First Submitted QC: 2015-09-18
• Study First Posted: 2015-09-22
• Study Start: 2015-10-19
• Primary Completion: 2018-03-19
• Study Completion: 2018-03-19
• Status Verified: 2019-07
• Last Update Submitted: 2019-07-02
• Last Update Posted: 2019-07-05

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 3423

Inclusion Criteria

-Patients with itching associated with allergic conjunctivitis.

Exclusion Criteria

-Patients with hypersensitivity to Lastacaft® or its components.

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Arm && Interventions

Group	Intervention	Description
Lastacaft®	Alcaftadine Ophthalmic Solution 0.25%	One drop of Lastacaft® Ophthalmic Solution 0.25% (Alcaftadine) in each eye daily as prescribed as standard of care in clinical practice.

Primary Outcome Measures

Name	Time	Method
Number of Participants with Adverse Events	2 Weeks

Trial Locations

Locations (76)

Seo-myeon St.Mary's Hospital; 🇰🇷 Busan, Korea, Republic of

SeoMyeon St. Eye Clinic; 🇰🇷 Busan, Korea, Republic of

Inje University Busan Paik Hospital; 🇰🇷 Busan, Korea, Republic of

Soojung Eye Hospital; 🇰🇷 Busan, Korea, Republic of

Inje University Haeundae Paik Hospital; 🇰🇷 Busan, Korea, Republic of

Saint Mary Bright Eye Clinic; 🇰🇷 Busan, Korea, Republic of

Daeyeon St.mary's Eye Center; 🇰🇷 Busan, Korea, Republic of

Dong-A University Hospital; 🇰🇷 Busan, Korea, Republic of

Pusan National University Hospital; 🇰🇷 Busan, Korea, Republic of

Pusan National University Yangsan Hospital; 🇰🇷 Busan, Korea, Republic of

Scroll for more (66 remaining)